This trial uses a shorter, more intense course of radiation to treat soft tissue sarcomas. The hope is that it will allow patients to be treated more quickly with similar rates of controlling the cancer.
1 Primary · 5 Secondary · Reporting Duration: Approximately 2 years
40 Total Participants · 1 Treatment Group
Primary Treatment: Hypofractionated Radiotherapy · No Placebo Group · Phase 2
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: